Lung Cancer News and Research

Latest Lung Cancer News and Research

BioCurex reports first set of results supporting RECAF blood test for monitoring cancer therapy

BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.

9 Jul 2010

ESMO releases revised set of clinical guidelines for cancer patient care

The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.

8 Jul 2010

20% of Canadians less sympathetic towards lung cancer sufferers

Canadian lung cancer patients are likely to suffer significant stigma due to the disease's link to smoking, a connection that may impact the care and treatment patients receive. According to a 16-country survey carried out by Ipsos MORI on behalf of The Global Lung Cancer Coalition, one in five Canadians admit feeling less sympathetic towards lung cancer sufferers because of its known association with smoking cigarettes and other tobacco products.

8 Jul 2010

Optics Express publishes special focus issue on lung cancer imaging research

Advanced imaging technologies that promise to improve the development of effective drugs to treat lung cancer are the focus of the current special issue of Optics Express, an open-access journal published by the Optical Society (OSA). Research featured in the special focus issue on Imaging in Diagnosis and Treatment of Lung Cancer outlines standardized approaches to measure and compare tumor size, as well as to validate the accuracy of such measurements under defined settings.

8 Jul 2010

Omni Health Media announces launch of CancerConnect.com

Omni Health Media, one of the world's leading specialty publishers of health-related information, websites, applications, and educational programs for individuals with cancer and their caregivers announces the successful launch of CancerConnect.com during the Allen Media Conference in Sun Valley, ID. Cancer Connect is a new social network that will allow people with cancer and those who care for them to share information, inspiration, hope, and support.

8 Jul 2010

Overall cancer mortality rates continue to decrease, new report shows

The continued drop in overall cancer mortality rates over the last 20 years has averted more than three-quarters of a million (767,000) cancer deaths according to a new report from the American Cancer Society. The American Cancer Society's annual Cancer Statistics article reports that the overall death rate from cancer in the United States in 2007 was 178.4 per 100,000, a relative decrease of 1.3 percent from 2006, when the rate was 180.7 per 100,000, continuing a trend that began in 1991 for men and 1992 for women.

8 Jul 2010

Experts urge community to get behind bowel cancer screening

University of Sydney experts say around 1000 bowel cancer deaths could be prevented every year if a fully-funded, evidence-based bowel cancer screening program was implemented by the Australian Government.

5 Jul 2010

American College of Surgeons CoC launches national pilot study for ProvenCare Lung Cancer Collaborative

A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons.

3 Jul 2010

People with high levels of vitamin B6 and methionine less likiely to develop lung cancer

People with higher blood levels of vitamin B6 and the amino acid methionine appear to have a lower risk of lung cancer, a French study has found. But more research is needed to understand if higher levels of the nutrients directly protect against the disease.

3 Jul 2010

IBM, University of Missouri collaborate to develop cloud computing environment for genomics research

IBM and the University of Missouri today announced a life sciences research initiative using IBM high performance computing technologies to advance the school's bioinformatics research projects. The goal of the initiative is to develop a first-of-a-kind cloud computing environment for genomics research collaboration at a regional level.

2 Jul 2010

SNMTS honors contributions in nuclear medicine and molecular imaging at 57th Annual Meeting

SNM's Technologist Section (SNMTS)-an international scientific and medical organization-recognized the contributions and work to the field of nuclear medicine and molecular imaging during its 57th Annual Meeting in Salt Lake City. Several awards ceremonies were held to recognize the value that SNMTS members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Jul 2010

Cancer stem cells may vary from tumor to tumor, say researchers

Cancer stem cells have enticed scientists because of the potential to provide more durable and widespread cancer cures by identifying and targeting the tumor's most voracious cells.

2 Jul 2010

FDA grants Cyclacel's sapacitabine orphan drug designation for AML and MDS

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's sapacitabine (CYC682) product candidate for the treatment of both acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

1 Jul 2010

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.

1 Jul 2010

Latest health disparity report examines trend of higher tobacco use among LGBT community

The American Lung Association's latest health disparity report, Smoking Out a Deadly Threat: Tobacco Use in the LGBT Community, examines the trend of higher tobacco use among the lesbian, gay, bisexual and transgender community and the need for additional research specific to this community.

1 Jul 2010

ResponseDX: Lung genetic test panel launched to detect EML4-ALK gene variants in lung cancer patients

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.

1 Jul 2010

Celgene signs definitive merger agreement to acquire Abraxis BioScience

Celgene Corporation and Abraxis BioScience Inc. today jointly announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Abraxis BioScience. Under the terms of the merger agreement, each share of Abraxis BioScience common stock will be converted into the right to receive an upfront payment of $58.00 in cash and 0.2617 shares of Celgene common stock.

30 Jun 2010

New approach to lung cancer measurement holds promise for smokers

The pilot program for Lung Cancer Alliance's (LCA) website for patient donated scans is helping open the door to a potentially new method for evaluating lung cancer risk in smokers as well as non-smokers.

30 Jun 2010

Data published in Cancer Research demonstrates proof of concept for Mirna's tumor suppressor miRNAs

Mirna Therapeutics announced today publication of new results in the journal Cancer Research demonstrating proof of concept that the systemic delivery of tumor suppressor microRNAs (miRNA) inhibits tumor growth by restoring the proper regulatory pathways required for cell cycle arrest and apoptosis.

30 Jun 2010

Guidance on ways to protect protect unborn babies from secondhand smoke exposure

New guidance from the National Institute for Health and Clinical Excellence (NICE) suggests that testing pregnant mothers would help to ensure they receive appropriate support they need to quit for good or reduce their exposure to secondhand smoke.

30 Jun 2010

Lung Cancer News and Research

Latest Lung Cancer News and Research

BioCurex reports first set of results supporting RECAF blood test for monitoring cancer therapy

ESMO releases revised set of clinical guidelines for cancer patient care

20% of Canadians less sympathetic towards lung cancer sufferers

Optics Express publishes special focus issue on lung cancer imaging research

Omni Health Media announces launch of CancerConnect.com

Overall cancer mortality rates continue to decrease, new report shows

Experts urge community to get behind bowel cancer screening

American College of Surgeons CoC launches national pilot study for ProvenCare Lung Cancer Collaborative

People with high levels of vitamin B6 and methionine less likiely to develop lung cancer

IBM, University of Missouri collaborate to develop cloud computing environment for genomics research

SNMTS honors contributions in nuclear medicine and molecular imaging at 57th Annual Meeting

Cancer stem cells may vary from tumor to tumor, say researchers

FDA grants Cyclacel's sapacitabine orphan drug designation for AML and MDS

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Latest health disparity report examines trend of higher tobacco use among LGBT community

ResponseDX: Lung genetic test panel launched to detect EML4-ALK gene variants in lung cancer patients

Celgene signs definitive merger agreement to acquire Abraxis BioScience

New approach to lung cancer measurement holds promise for smokers

Data published in Cancer Research demonstrates proof of concept for Mirna's tumor suppressor miRNAs

Guidance on ways to protect protect unborn babies from secondhand smoke exposure

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in